Ideas to Action:

Independent research for global prosperity

Publications

 

Cover of Policy Paper 117
January 26, 2018

Structuring and Funding Development Impact Bonds for Health: Nine Lessons from Cameroon and Beyond

Despite the considerable interest in Development Impact Bonds, only a few have reached the implementation phase. We use information from stakeholder interviews to describe the design of one DIB in-depth and use lessons from a range of impact bonds to develop recommendations for potential partners to future DIBs. Lessons from the set of impact bonds reveal a need to reset expectations, particularly around the time and effort needed to develop and market a DIB. 

Roxanne Oroxom , Amanda Glassman and Lachlan McDonald
November 15, 2016

Nigeria Will Become Polio-Free: Challenges, Successes, and Lessons Learned for the Quest to Eradicate Polio

Despite no reported cases of polio in two years in Nigeria, on August 11, 2016, the WHO announced two new wild polio cases had been discovered in Northern Nigeria. While undoubtedly a setback, Nigeria has mobilized its immunization forces and will look to take heed of four key lessons learned during almost three decades of anti-polio efforts: 1) establishing and sustaining trust is critical to the success  of eradication campaigns; 2) frequent, independent monitoring and evaluation are key to tracking the progress of an intervention and making modifications; 3) holding all actors accountable is essential to pushing an intervention forward; and 4) contextualized health initiatives are key in fighting polio and other diseases. These lessons will reinforce a cohesive, multilateral strategy that builds on past successes to secure a polio-free Nigeria.

David Boyd , Alykhan Premji , Paige W. Sholar , Azfar Hossain , Kunal Potnis , Lisa Wanda , Jamal Edwards , Laura Winn and Lexia Chadwick
March 4, 2015

Benchmarking Supply Chains for Better Performance

Donors play a significant role in funding medicines and other commodities in global health. Of the approximately US $28.2 billion spent by donors in 2010, approximately 40% went towards medicines, vaccines and other health commodities, mainly in sub-Saharan Africa. The efficiency of this spend is therefore of great concern, given the large variability in supply chain costs.

Ananth Iyer , Gemma Berenguer , Prashant Yadav and Amanda Glassman